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Objectives: Most DAMPs in inflammatory diseases are TLR2- and TLR4-ligands and
according to the current concept, repeated stimuli would result in tolerance. Aims of
the study were to verify this assumption, to investigate whether epigenetic effectors are
involved and to explore the situation in rheumatoid arthritis (RA).
Methods: A trained immunity (TI) and tolerance protocol was established using
peripheral bloodmonocytes from healthy donors, β-glucan and lipopolysaccharide (LPS).
The training or tolerance capacities of RA-relevant DAMPs were tested.
Results: β-Glucan-, oS100A4-, HMBG1-, and HSP90-pretreated monocytes showed
increased IL-6 responses to LPS re-stimulation. β-Glucan, oS100A and tenascin C
induced training of monocytes to release more TNFα. In comparison to β-glucan,
most DAMPs tested induced less TI, with exception of oS100A4. Monocytes
exposed to oS100A4 showed increased IL-1β, IL-6, and TNFα in response to
LPS, in spite that both stimulate TLR4. RNASEq upon β-glucan or oS100A4
revealed similar changes in chemokines/cytokines and epigenetic effectors; 17
epigenetic effectors correlated with chemokine/cytokine gene expression; PRDM8
was associated with more chemokine and cytokine transcripts. Knockdown of
PRDM8 abolished TI induced by oS100A4. In RA, plasma S100A4 correlated
with increased CSF2, and increased PRDM8 transcription in RA monocytes was
associated with increased plasma CCL5 and IL-6, as well as therapy-resistance.
Neidhart et al. DAMPS and Trained Immunity
Conclusion: Bypass of tolerance by DAMPs might be a phenomenon as important
as TI, since it could explain how chronic inflammation can be maintained in spite of an
environment with multiple TLR2/TLR4-ligands. In RA monocytes, a PRDM8-dependent
TI mechanism could be responsible for sustained chemokine/cytokines levels.
Keywords: trained immunity, DAMPs, S100A4 protein, epigenetic, rheumatoid arthritis
INTRODUCTION
Monocytes and macrophages play a central role in the
pathophysiology of inflammation. For instance, in rheumatoid
arthritis (RA), activated monocytes massively infiltrate synovial
tissues and produce tumor necrosis factor-α (TNFα) (1–3).
Accordingly, therapies aimed at blocking this cytokine have
emerged as a major tool in the treatment of RA and other
inflammatory diseases (4, 5). These observations indicate the
essential role of TNFα in the pathogenesis of RA. Indeed, RA
synovial fibroblasts have an intrinsic ability to destroy cartilage
and bone due to epigenetic changes (6), and TNFα further
stimulates their aggressive behavior (7).
Abnormal activation of pattern recognition receptors
(PRRs), like Toll-like receptors (TLRs) and receptors for
advanced glycation end products (RAGE) by endogenous
danger signals (damage-associated molecular patterns;
DAMPs) as well as infectious agents (pathogen-associated
molecular patterns; PAMPs) has been suggested to be crucial
for perpetuating vicious inflammatory cycles (8–10). In
RA, of special interest is the oligomeric form of S100A4
(oS100A4), which is a potent trigger of pro-inflammatory
cytokines found in plasma of patients with RA (11–13).
Various cell types, mostly activated fibroblasts, release S100A4
(11, 12, 14). The effect of S100A4 on the production of
proinflammatory cytokines is mainly mediated by TLR4
(13). Similar properties in driving persistent inflammation
in RA has been suggested for extracellular HSP90 (14),
tenascin C (15), HMGB1) (16), biglycan (17), and citrullinated
fibrinogen (18).
Recently, it was shown that innate immune cells during
initial challenge with pathogens become trained and successively
undergo long-term adaptive changes in their functional
programs, resulting in altered gene expression and cell
physiology upon re-stimulation with the pathogen (19–21).
This de facto novel kind of immunological memory has been
termed trained immunity (TI) or innate immune memory.
An in vitro TI protocol has been developed to explore the
mechanisms governing the TI phenomenon (19, 22, 23). It has
been reported that CD14+ monocytes or PBMCs pre-treated
with heat-inactivated Candida albicans or its most potent
component, β-glucan, increases production of IL-6 and TNFα
upon re-stimulation with different non-related microbial stimuli.
Similar training properties to β-glucan has been implicated for
many other PAMPs (23). Of great importance is that dependently
on PRR engaged and dosage regimen applied, tolerance (i.e.,
decreased cytokine production) instead of training could
be induced). The current concept predicts possible training
upon stimulation of different receptors and pathways, while
sequential stimulation of receptors triggering common pathways
result in tolerance (23, 24). Training or tolerance occur
depending on the stimuli, sequence of stimulation, doses and
signaling pathways.
TI in relation to endogenous danger stimuli has been shown
for oxidized low density lipoproteins (25) and lipoprotein A
(26). Possibly, alarm signals associated with tissue damage
and sterile inflammation can induce TI through epigenetic
regulation of transcriptional programs. A concern regarding
TI in a disease such as RA is that mostly all circulating
DAMPs are recognized by TLR2 and/or TLR4. According to the
concept above, it could be expected that subsequent stimulation
with LPS or repeated exposure with DAMPs will result in
tolerance. We report here that oS100A4 shows important
training abilities and induces cellular changes allowing to bypass
tolerance to subsequent TLR4 ligands, including LPS. Here,
we propose that histone methylase PRDM8 plays a pivotal
role in DAMPs-induced TI. Such a mechanism might be
relevant in chronic inflammatory diseases. It can be hypothesized
that TI and bypass of tolerance in RA might explain the
association with e.g., increased risk for atherosclerosis (27).
Thus, elucidation of this pathway would potentially reveal novel
pharmaceutical targets.
MATERIELS AND METHODS
Recombinant Human Proteins
and Reagents
The selection of DAMPs was done according to the literature
[e.g., ref. (13–18)] and based on following criteria: (1) known
receptors, (2) receptors present on monocytes/macrophages,
(3) described effect on monocyte/macrophages, (4) released as
alarmins from other cells/tissues, and (5) relevance to RA.
Recombinant human proteins were used: HSP90/GRP94
(Abcam), tenascin C, HMBG1, biglycan, and S100A4 (R&D
Systems). In addition, purified human oS100A4 was provided
by M. Grigorian (Copenhagen University, Copenhagen, DK).
β-Glucan isolated from Candida albicans was provided by the
department of internal Medicine, Radboudumc (Nijmegen, NL).
Other compounds used in the current study included human
fibrinogen and citrullinated fibrinogen (Cayman), muramyl
dipeptide (MDP), E. coli lipolpolysaccharide-B5, Salmonella
typhimurium flagellin and ATP (Sigma). All DAMPs were tested
for endotoxin contamination, using the Pierce LALChromogenic
Endotoxin Quantification Kit. SNX482 (Tocris) was diluted to
25 nM in RPMI.
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Preparation of Monocytes From Human
Buffy Coats and Peripheral Blood
Mononuclear Cells
In Figures 1, 2, buffy coats from healthy donors (n = 8, Red
Cross, Schlieren, Switzerland) were diluted 5-times with PBS;
35ml diluted blood were underlayed with 15ml Ficoll-Paque
Plus (GE Healthcare) and centrifuged at 400 g for 35min.
The cell layer (PBMCs) were washed in PBS, resuspended in
RPMI+ (RPMI1640 containing GlutaMAX, HEPES, PenStrep
and pyruvate) and counted. Three ml PBMCs (150 to 200 ×
106 cells) were layered on 10ml 48.5% hyperosmotic Percoll
solution (48.5ml Percoll Plus [GE Healthcare] diluted in 41.5ml
sterile water and 10ml 1.6M NaCl) and centrifuged at 580 g
for 15min. The interphase was collected, washed in PBS, and
centrifuged down at 400 g for 10min. RMPI+ were added to the
cell pellet and this suspension is referred as “monocyte-enriched
suspension.” The cells were counted and checked for viability.
In the other experiments (Figures 3–6, 8), EDTA peripheral
blood of healthy donors were used to isolate PBMCs by Ficoll-
Paque. PBMCs were washed 2-times in cold MACS buffer,
centrifuged, resuspended in RPMI+ containing 1% human
serum, and counted. Monocytes were isolated by the addition of
20 µl anti-CD14 beads/107 cells in 80 µl MACS buffer (Milteny
Biotec). After an incubation of 15min at 4◦C, the cells were
washed in cold MACS buffer, centrifuged and resuspended in 50
µl MACS buffer per 107 cells, followed by magnetic separation.
CD14+ cells were resuspended in RPMI+ including 1% human
serum, counted and used for stimulation, as well as training and
tolerance experiments.
Monocyte Training and Tolerance
Experiments
Monocyte-enriched suspensions of 2 × 106 cells/ml were
prepared in RPMI+ (n = 8). The cells were distributed in 96-
wells plate (200’000 cells in 100 µl per well) and incubated at
37◦C for 1 h to let them to adhere. Non-adherent cells were
removed (mostly CD3+, CD14- T-cells). The cells were washed
with warm PBS to remove the rest of non-adherent cells. Next,
the cells were incubated in 200ml RPMI+ including 1% human
pooled serum at 37◦C for 24 h. This procedure was repeated two
other times and results in a population of >95% CD14+ and
< 5% CD3+ cells, as checked by flow cytometry. Training was
performed similarly to previous protocols (19, 22, 23). Briefly,
as positive controls, monocytes were trained with 1µg/ml β-
glucan in RPMI+ containing 1% pooled human serum. RPMI+
with human serum served as a negative control. The cells were
incubated for 24h at 37◦C, before changing the medium. In a
first set (Figure 1, Supplementary Figure 1), increasing doses
of DAMPs or defined doses of PAMPs (e.g., LPS, PAM3CSK4,
flagellin) allowed to differentiate between doses resulting in
training or tolerance. In a second set (Figures 2A,B), monocytes
were exposed for 24 h tor increasing doses of S100A4/oS100A4
(1 to 10µg/ml). A part of the cells were pre-treated with
LPS (1 ng/ml) followed by 3 days rest before re-stimulation
with increasing doses of oS100A4 (Figures 2C,D). Finally, a
part of the cells were pretreated with increasing doses of
oS100A4 followed by 3 days rest before re-stimulation with LPS
(10 ng/ml) (Figures 2E,F).
Chemokine and Cytokine ELISA
For cell culture supernatants: IL-1β/IL-6/TNFα (BD OptEIA
Human ELISA Sets, BD Bioscience), CCL5 (Quantikine
R&D Systems), CXCL1 (Platinum ELISA, eBioscience) and
CCL20/CSF2 (Human ELISA Kit, Thermo-Fisher), accordingly
to manufacturer’s protocols. For EDTA plasma: S100A4
(Aviva Systems Biology), Human IL-1β/TNFα Quantikine
HS ELISA, CCL5/IL-6 Quantikine ELISA (R&D Biosystems),
CSF2/CCL20/CRP ELISA (Thermo-Fisher), and CXCL1
Platinum ELISA (eBioscience).
RNA Extraction and Quantitative
Real-Time PCR (qRT-PCR)
RNA was isolated from monocytes using the RNA MicroPrep
kit (Zymo Res.), according to the manufacturer’s instruction;
qRT-PCR was done to confirm upregulated genes and to verify
the effect of siRNA. Reverse transcription was performed using
10 nM dNTP, RNase inhibitor, random hexamer, Multiscribe
Reverse Transcriptase and GenAmp PCR Buffer II (all from
Thermo Fisher). qRT-PCR was conducted on an Applied
Biosystems 7900HT Fast Real Time PCR System, using FastStart
Universal SyBr Green Master Mix (Roche) (primer pairs
listed in Table 1).
Transcriptome Arrays
Five samples with 3 conditions were selected (healthy male blood
donors 43 ± 11 years old). Conditions included unstimulated
controls and stimulation with 1µg/ml β-glucan or 2µg/ml
oS100A4. Adjusted volumes and cell densities for 12-well
plate were 1.2 x 106 cells/well and 1.2ml medium/well. After
incubation at 37◦C for 24 h, cell culture supernatants were
collected. Integrity of RNA was evaluated by agarose gel
electrophoresis using an Agilent Bioanalyzer. RNA quality
was controlled by RNA electropherograms and by using
the RNA integrity number (RIN) resulting from an Agilent
software algorithm. In cooperation with the Functional Genomic
Center Zurich, poly A mRNA selection was performed using
magnetic beads before cDNA synthesis. The cDNA libraries
were sequenced using the Illumina Hiseq Sequencer. Generated
were alignment QC, transcripts’ expression quantification and
differential expression analysis between conditions. Filtering of
low read counts was applied, eliminating weakly or sporadically
expressed genes. Selected were normalized genes up-regulated by
>2-times (mean and median).
Proteomic Array
The Proteome ProfilerTM Human XL Cytokine Array (R&D
Systems) was performed with cell culture supernatants of the
transcriptome experiment, accordingly to the manufacturer’s
protocol. The cytokine/chemokine/growth factors profiles upon
β-glucan and oS100A4 were compared.
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FIGURE 1 | Training and tolerance induced by DAMPs. (A) Training/tolerance protocol. (B,C) Low doses of DAMPs can increase the response to LPS. (D,E) Higher
doses of DAMPs, however, can induce tolerance to LPS. The effects were DAMPs- and read-out-dependent (box-and-whisker plots, comparison of medians using
Mann-Whitney U-test, *p < 0.05, **p < 0.01, *** p < 0.001, compared to controls without first stimulus, n = 8 healthy donors). Optimal doses in this experiment were
following: (B,C) training: β-glucan 1µg/ml, biglycan 0.5µg/ml, fibrinogen 0.15µg/ml, citrullinated fibrinogen 0.15µg/ml, HMGB1 2.5µg/ml, HSP90 1.25µg/ml,
muramyl dipeptide (MDP) 1µg/ml, oS100A 5µg/ml, S100A4 5µg/ml, tenascin C 1.25µg/ml; (D,E) tolerance protocol: Flagellin 5 ng/ml, LPS 1 ng/ml, PAM3CSK4
0.5µg/ml, ATP 0.31µg/ml, biglycan 1µg/ml, fibrinogen 1µg/ml, citrullinated fibrinogen 1µg/ml, HMBG1 5µg/ml, HSP90 5µg/ml, MDP 5µg/ml, oS100A4 10µg/ml,
S100A4 10µg/ml, tenascin C 5µg/ml.
Flow Cytometry
CD14+ monocytes were isolated with magnetic beads as
described above and incubated for 24 h with medium or 2µg/ml
oS100A4 (n = 6). Before staining, cells were permeabilized
using Perm 2 solution (BD Bioscience). Binding of primary
polyclonal rabbit anti-CITED4, HMGA2, MN1, or PRDM8
antibodies was followed by secondary staining using PE-goat
anti-rabbit F(ab)2 (Invitrogen). Binding of murine monoclonal
anti-GADD45B (Lucerna Chem.) or anti-DNMT3B (Miltenyi)
was followed by secondary staining using PE-rabbit anti-
mouse F(ab)2 (Invitrogen). Rabbit polyclonal anti-human SCIN
antibodies were conjugated with FITC (LSBio). The expression
was tested in THP1, PMA-differentiated THP1 cells, as well as in
primary monocytes.
Transfection
CD14+ monocytes (n = 4 healthy donors) were seeded into
24-wells plates. Mock or siRNA against PRDM8 transcripts
(Thermo-Fisher AM16708/133027) transfections were
performed using lipofectamine 2000, as described by the
manufacturer (Thermo-Fisher). Two µg/ml oS100A4 were
added after 24 h, corresponding to the time of maximal PRDM8
mRNA knockdown. Cell culture supernatants were collected
after 3 days and the medium was replaced by RPMI+ containing
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FIGURE 2 | Effects of S100A4 and LPS. (A,B) Dose-response curves of homodimeric S100A4/oligomeric oS100A4 regarding increased releases of IL-6 and TNFα
into the cell culture supernatant. (C,D) The effect of LPS pre-treatment (1 ng/ml) on the response to oS100A4 (1-10µg/ml). (E,F) the effect of
oS100A4-pre-treatement (1–10µg/ml) on the response to LPS (10 ng/ml) (n = 8 healthy donors, Mann–Whitney U-test, *p < 0.01 vs. controls without first stimulus).
LOED: lowest effective dose, EC70: refers to the concentration of a compound, which induces a response 70% between the baseline and maximum after 24 h.
1% human serum and 10 ng/ml LPS. After 24 h of incubation,
cell culture supernatant was collected and analyzed by ELISA.
RA Plasma and Monocytes Cohort
EDTA-plasma and peripheral blood monocytes were collected
from 36 RA outpatients (58 ± 10 years old) visiting the Clinic
of Rheumatology at University Hospital, Zurich, as well as from
18 healthy controls (56± 12 years old), and RNAwas prepared as
previously described. The local ethical commission accepted the
protocol and patients gave their informed consent (Basec 2019-
0015). The samples and related clinical data were anonymized.
All patients fulfilled the ACR/EULAR 2010 classification criteria
for RA. In average, RA patients had an ESR of 5.0 ± 4.8 mm/h,
CRP of 13.6 ± 15.1 mg/L and a DAS28 of 2.8 ± 1.2. The
seropositivity for IgM-RF and anti-CCP positivity were 81 and
78% (78% were positive for both and 5% were seronegative).
Treatments included Rituxumab (76% of patients), Methotrexate
(41%), Tocilizumab (34%), and Leflunomid (24%). Remission
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TABLE 1 | Primer pairs used for SYBR green quantitative RT-PCR.
CCL5 fwd 5′-CGCTGTCATCCTCATTGCTA-3′, rev 5′-GCACTTGCCACTGGTGTAGA-3′;
CCL20 fwd 5′GCGAATCAGAAGCAGCAAGC-3′, rev 5′-GATGTCACAGCCTTCATTGG-3′
CSF2 fwd 5′-AATGTTTGACCTCCAGGAGCC-3′, rev 5′-AGTGCTGCTTGTAGTGGCTG-3′;
CXCL1 fwd 5′-GAAAGCTTGCCTCAATCCTG-3′, rev 5′-CTTCCTCCTCCCTTCTGGTC-3′;
CXCL8 fwd 5
′
-GAAGTTTTTGAAGAGGGCTGAGA-3′, rev 5′-TCCTTGAAGTTTCACTGGCAT-3′;
IL1B fwd 5
′
-CTCTTCGAGGCACAAGGCAC-3′, rev 5′-TGGCTGCTTCAGACACTTGAG-3′;
IL6 fwd 5′-CCCTGAGAAAGGAGACATGTAAC-3′, rev 5′-CCTCTTTGCTGCTTTCACACATG- 3′;
TNFA fwd 5′-AGCCCATGTTGTAGCAAACCC-3′, rev 5′-TCTCTCAGCTCCACGCCATT-3′.
PRDM8 fwd 5′-CTTGCCTCCACTTCATAATGTCA-3′, rev 5′-GCTTTGACAGCCTGGTGACT-3′.
HPRT1 fwd 5′-CCTGGCGTCGTGATTAGTGA-3′, rev 5′-CGAGCAAGACGTTCAGTCCT-3′.
was defined as a DAS28 score < 2.6, combined with BSR < 20
mm/h and CRP < 5 mg/l.
Statistics
Mann–Whitney U-test was used for comparison between groups
andWilcoxon signed-rank test between control and stimulations.
Spearman’s rank correlation analysis allowed finding possible
relationships between variables. Heat-maps using Z-scores were
constructed using http://www.heatmapper.ca/expression/ after
normalization to β-actin transcription. Venn diagrams were
used to illustrate and select epigenetic effectors associated
with chemokines/cytokines gene expressions. Two component
(C1, C2) analysis was performed using means of correlation
coefficients for given chemokine/cytokines and epigenetic
effectors. This allowed to clearly distinguish clusters.
RESULTS
DAMPs Induction of Trained Immunity
In the first set of experiments, monocytes isolated from 8 buffy
coats were exposed to different doses of DAMPs and PAMPs
before re-stimulation with LPS (Figure 1A). Figures 1B–E
present TI or tolerance using optimal doses for IL-6 and TNFα
releases. The dose ranges inducing TI were following (also
shown in Supplementary Figure 1): For IL-6, oS100A4 2.5–
5.0µg/ml, HMBG1 1.25–5.0µg/ml and HSP90 0.31–1.25µg/ml
(Figure 1B); for TNFα, oS100A4 2.5–5.0µg/ml, tenascin C
0.31–1.25µg/ml and MDP 0.15–1.25µg/ml (Figure 1C). In
comparison to β-glucan, most DAMPs tested produced much
lower training, with exception of oS100A4. For each DAMPs and
read-outs, optimal doses have to be determined.
DAMPs and Endotoxin Tolerance
At higher doses, DAMPs can induce tolerance, i.e., reduced
the response to a subsequent LPS stimulation (Figures 1D,E).
Again, the effect was dose-and read-out dependent: for IL-
6, citrullinated fibrinogen and ATP ≥0.31µg/ml (Figure 1D);
for TNFα, tenascin C ≥2.5µg/ml, ATP ≥0.15µg/ml, biglycan
≥1µg/ml, citrullinated and native fibrinogen ≥0.61µg/ml
(Figure 1E). However, tolerance induced by DAMPs were weaker
compared to repeated stimulation with PAMPs.
Dose-Response Curves Upon S100A4
or oS100A4
In a second set of experiments using monocytes isolated from
8 additional buffy coats, we focused on the effects of oS100A4.
As expected, oS100A4, compared to its homodimeric form,
showed a much higher efficiency to induced pro-inflammatory
cytokines, as shown by the release of IL-6 and TNFα after 24 h
(Figures 2A,B).
Sequences With LPS and oS100A4
Monocytes were pre-treated with LPS (1 ng/ml for 24 h) and
3 days later re-stimulated with increasing doses of oS100A4
(Figures 2C,D). Under such conditions, monocytes showed
an oS100A4 dose-dependent induction of tolerance. Next, we
investigated the dose-dependent effect of pre-treatment with
oS100A4 on the subsequent response to LPS (Figures 2E,F).
Monocytes were exposed to different concentrations of oS100A4,
the medium was changed after 24 h, and after 3 more days,
LPS was added. In contrast to the previous sequence, oS100A4-
primed monocytes showed increased IL-6 and TNFα in response
to LPS. Regarding IL-6, training occurred also at higher doses (4–
10µg/ml) without induction of tolerance (Figure 2E). For TNFα,
a tight dose windowwas associated with training (2–4µg/ml), the
effect being abolished at higher doses (Figure 2F).
Confirmation Experiments
In a third set of experiments, we investigated different
combinations between β-glucan (1µg/ml as first or 10µg/ml
as second stimulus), oS100A4 (2µg/ml as first or 5µg/ml as
second stimulus) and LPS (1 ng/ml as first or 10 ng/ml as second
stimulus). β-Glucan trained monocytes showed increased IL-
6 and TNFα responses to oS100A4, similarly as they would
respond to LPS. As observed in the previous sets, LPS-pre-treated
monocytes induce tolerance when challenged by oS100A4. Of
note, oS100A4 increased the release of IL-1β and CSF2, but these
cytokines were not affected by pre-treatments with β-glucan or
LPS, i.e. monocytes became not trained or tolerant for those read-
outs. More important were the effects of oS100A4 as training
stimulus. oS100A4-primed monocytes potentiated the effect
of β-glucan, similarly to LPS-pre-treated cells. This included
increases of IL-6, TNFα and IL-1β, but not CSF2 which was
already maximally stimulated by oS100A4. It was confirmed that
oS100A4-priming did not induce tolerance to LPS. At opposite,
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this sequence and combination even significantly increased the
release of IL-1β and IL-6 (changes of TNFα levels in this set were
not significant). oS100A4 re-challenged doesn’t induce tolerance
to itself (Supplementary Figure 2).
β-Glucan-Stimulated
Chemokines/Cytokines
Quantitative RT-PCR revealed upregulated transcription
of CCL20, CXCL1, CXCL8, CSF2, IL1B, and IL6 by 3.5 to
12-times (Supplementary Figures 3A,B). CCL5 and TNF
mRNAs were increased by 2-times only. A proteome array
provided information regarding released factors after 24 h
stimulation of monocytes with training doses of β-glucan
(Supplementary Figure 4B). Only an increased release of CCL5
was detected. This was confirmed by ELISA.
oS100A4-Stimulated
Chemokines/Cytokines
Quantitative RT-PCR revealed upregulated transcription of
numerous chemokines/cytokines, including CCL5, CCL20,
CXCL1, CXCL8, CSF2, IL1B, and IL6 by 7- to 150-fold
(Supplementary Figures 3A,B). TNF mRNA was unchanged.
The proteome array showed that oS100A4 had a much broader
effect than β-glucan, with increased releases of CCL5, CCL20,
CXCL1, CXCL5, CSF2, IL-1β, and IL-6, while TNFα levels
in the cell culture supernatant was only minimally changed
(Supplementary Figure 4C). This was confirmed by ELISA.
RNA Sequencing
RNASeq provided more information about global gene
expression changes upon β-glucan or oS100A4. The following
analysis is based on genes that were upregulated 24 h after
stimulation with 1µg/ml β-glucan or 2 µg/ml oS100A.
oS100A4 and RNASeq
Upon stimulation of monocytes with oS100A4, a total of 1012
differentially expressed genes were divided as follow: among 902
genes with defined functions, 601 (66%) and 301 (34%) were
up- or downregulate, respectively (mean and median at least
> 2- or < 0.5-fold, normalized to β-actin transcription, p <
0.01). Functional categories with most differentially expressed
genes were (in order of numbers of genes): transcription
factors, growth factors and their receptors, degrading and
processing enzymes, cell-cell contact and signaling, cytokines and
their receptors, control of cell motility, chemokines and their
receptors, extracellular matrix, G-coupled adhesion molecules
and receptors, control of apoptosis and DNA repair, calcium
signaling, transmembrane transporters and solute carriers, RHO-
signaling, chromatin modifiers and epigenetic effectors, cell
adhesion and signaling, RAS-RAF signaling, protease inhibitors,
antimicrobial activities, transmembrane proteins with Ig-linked
domains, ubiquitinase, and proteasome-related proteins, as well
as transcription regulators and repressors. Highly upregulated
in comparison to unstimulated controls were CSF2, CSF3,
IL12B, PTGS2, HAS1, CYP3A5, IL24, IL20, MUCL1, TNC,
IL6, IL2RA, IL19, and HHLA2. The category with most
upregulated genes were transcription factors (45 genes), while
the most downregulated genes were transcription regulators
and repressors (18 genes). Because TI protocols used pro-
inflammatory cytokines as read-outs, the analysis below will
focus on chemokines/cytokines and epigenetic effectors.
Chemokines and Cytokines
Upon β-glucan or oS100A4 stimulation
(Supplementary Figures 5A,B), transcripts of 15 and 18
chemokines were significantly upregulated; 15/18 (83%) were
in common between both stimuli. The difference between
β-glucan and oS100A4 was more quantitative than qualitative.
After both stimuli, CCL5 release was increased, as measured
by ELISA (not shown). Similarly, upon β-glucan or oS100A4
(Supplementary Figures 5A–D), transcripts of 16 and 17
cytokines were upregulated; 16/19 (84%) were in common. Upon
oS100A4, but not after β-glucan, CSF2, CCL20, and CXCL1 were
released into the cell culture supernatant (not shown).
Epigenetic Effectors
Upon β-glucan (Figure 3A) or oS100A4 stimulation (Figure 3B),
transcripts of 13 and 22 epigenetic effectors were upregulated;
12/23 (52%) were in common. The heat map (Figure 3C) clearly
showed an oS100A4-related cluster.
Epigenetics effectors with increased transcription > 7-times
upon oS100A4 stimulation were confirmed at the protein level
by flow cytometry. In THP-1 cells, increased CITED4 occurred
upon oS100A4; other increases were obvious only in PMA-
differentiated THP-1 cells, e.g., MN1, HMG2A, and PRDM8. In
primary monocytes, increased expression upon oS100A4 were
confirmed for CITED4, DNMT3B, GADD45B, HMGA2, MN1,
and PRDM8 (Figure 3D).
Correlation heat-maps (Figures 4A–D) allowed to recognize
a cluster of 17 epigenetic effectors mRNAs associated with
the transcription of chemokines or cytokines (Figure 5A).
The Venn diagrams allow logical operations and revealed
relationships of epigenetic effectors with chemokines and
cytokines (Figure 5B), suggesting that KMT2E and PRDM8
might be major regulators of pro-inflammatory mediators in
both conditions. For simplification, the ranges highlighted
(white) in Figure 4 are called “KMT2E/PRDM8 clusters.”
Component analysis allowed using correlation coefficients
to clearly distinguish clusters of chemokines/cytokines
that could be associated with specific epigenetic effectors
(Figures 5C–F). For instance, both IL6 and TNF belong to the
KMT2E/PRDM8 cluster, but TNF might also be regulated by
effectors included in C2. Upon oS100A4, some chemokines
appeared in the left quadrants, suggesting that they are
down-regulated by those epigenetic effectors or regulated by
other factors.
Since KMT2E (MLL5) function might be more a regulator of
cell cycle progression than an epigenetic effector, we focused on
histone methylase PRDM8.
PRDM8 Knockdown and Training
Twenty-four hours of after transfection, siRNA directed against
PRDM8 transcripts reduced PRDM8 mRNA by 74% and
intracellular protein level by 55% (Figures 6A,B). Next, we
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FIGURE 3 | Changed gene expression of epigenetic effectors upon (A) β-glucan (1µg/ml) or (B) oS100A4 (2µg/ml), as revealed by RNASeq (box and whisker plots,
significantly increased mean and median > 2-fold, n = 5 healthy donor in duplicate). (C) Heat map of epigenetic effectors transcripts discriminating the three
conditions (controls [Co], β-glucan [βG] or oS100A4). (D) Increases in the cytoplasmic expression of selected epigenetic effectors in permeabilized monocytes upon
oS100A4, as measured by flow cytometry (n = 6 healthy donors, Wilcoxon signed-rank test). The clustering was unsupervised. For each donor and transcript, a
Z-score was calculated. Regarding a given transcript, the highest and lowest Z-scores are shown in green and red, respectively.
tested the effect of PRDM8 knockdown in a protocol of TI
(Figures 6C,D). Transfection was performed after isolation; this
was followed next day by exposure to oS100A4 for 24 h; after
additional 3 days, medium was replaced including LPS. PRMD8
knockdown significantly decreased the oS100A4-induced release
of cytokines over the first 3 days. Thereafter, oS100A4-primed
monocytes showed significantly increased responses to LPS,
reflecting a TI phenomenon. PRDM8 knockdown increased the
response of control monocytes to LPS. However, in the context
of oS100A4-primed monocytes, PRDM8 knockdown abolished
TI in response to LPS. These data clearly associate epigenetic
modulator PRDM8 with oS100A4-driven TI pathways.
S100A4 and CSF2 in RA
Patients with high S100A4 levels showed more CSF2 and CRP. In
RA patients, a significant relationship occurred between S100A4
and CSF2 (Figure 7A).
PRDM8, CCL5, and IL-6 in RA
qRT-PCR showed no significant difference in transcription of
PRDM8 between healthy donors and RA patients. Nevertheless,
in RA, PRDM8 transcription positively correlated with plasma
levels of CCL5 (Figure 7B). In RA patients not receiving
Tocilizumab, PRDM8 transcription positively correlated with
plasma levels of IL-6 (Figure 7C). Such relationships were not
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FIGURE 4 | Heat maps of correlations coefficients between Z-scores of epigenetic effectors and (A,C) chemokines or (B,D) cytokines. Values for (A,B) β-glucan- or
(C,D) oS100A4-stimulated cells were separately analyzed. Five healthy donors were evaluated in duplicate. The dendrogram reveals possible associations (arrows);
the so-called “KMT2E/PRDM8” cluster is highlighted. Spearman’s rank correlation coefficients between transcription levels of chemokines/cytokines and epigenetic
effectors were obtained. For each chemokine/cytokine, Z-scores were calculated. For a given chemokine/cytokine, highest and lowest coefficients are shown in green
and red, respectively. Epigenetic effectors were unsupervised and chemokine/cytokines were supervised.
observed in healthy donors. In our patient cohort, Tocilizumab
was associated with higher plasma levels of IL-6 and CCL20, but
lower CRP.
Lower PRDM8 and Disease Remission
The 36 RA patients were divided into 2 groups, depending on
their BSR, CRP, and DAS28 values. No remission was defined as
fulfilling 2/3 following criteria: BSR > 20 mm/h, CRP > 5 mg/L
and/or DAS28 score > 2.6. Taken all therapies together, poor
responders showed significantly higher PRDM8 transcription
(i.e., lower dCt values) than patients in remission (Figure 7D).
Differences Between β-glucan
and oS100A4
Among differences between β-glucan and oS100A4, three
important fact have to be noted (Figures 8A–D). Firstly,
as expected, training with β-glucan increased LPS-induced
transcription of IL6 and TNF. However, this is not the case
in oS100A4-primed monocytes (Figure 8A). An alternative
explanation for the increased release of pro-inflammatory
cytokines in oS100A4-primed monocytes upon exposure to
LPS regards modifications of the cytoskeleton, ion channels
and secretory machinery. Thus, scinderin (Figures 8B,C) was
downregulated, while numerous ion channels (example of a R-
type Ca++ channel Figure 8D) were upregulated. The effect
of SNX482 on THP-1 cells indeed suggested that such type of
Ca++ channel play a role in cytokine release upon stimulation
(Supplementary Figure 6).
DISCUSSION
Most DAMPs Induced Weak Training
In this study, we showed for the first time that RA-related
DAMPs, particularly oS100A4, can induce TI via epigenetic
reprogramming involving histone methylase PRDM8. This
mechanism might contribute to the well-known association
between RA and e.g., cardiovascular diseases and provide a novel
target for preventive pharmacotherapy.
Pre-treatment with DAMPs induced only weak training
in comparison to β-glucan, with exception of oS100A4, for
both IL-6 and TNFα. At higher doses, DAMPs can induce a
moderate tolerance, but not comparable to endotoxin/PAMPs re-
stimulations. The overall effect is dependent on the DAMP, doses
and read-out.
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FIGURE 5 | PRDM8 is a common epigenetic effector of β-glucan and oS100A4. (A,B) Possible relationships between chemokines/cytokines and epigenetic effectors
were analyzed using Venn diagrams. The diagram left illustrates the set of 17 epigenetic effectors mRNAs which are associated with the upregulated transcription of
chemokines or cytokines. The diagram right shows relationships of chemokines and cytokines, revealing KMT2E, and PRDM8 possibly as major regulators of
(Continued)
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FIGURE 5 | pro-inflammatory genes in both conditions. (C–F) Principal component analysis revealed distinct clusters. C1 was defined as the mean correlation of a
given chemokine/cytokine with KMT2E/PRDM8; C2 was defined as the mean correlation of a given chemokine/cytokine with EID3, HADC7, HDAC11, L3MTDL4,
MBD3, and PRDM5 (on the heat map Figures 4A–D, they are positively associated with chemokines/cytokines outside of the so-called KMT2E/PRMD8 cluster). In
the lower right quadrant are chemokines/cytokines that could be regulated by the “KMT2E/PRDM8” cluster. In the upper right quadrant are chemokines/cytokines
that in addition might be modulated by other epigenetic effectors, i.e., those included in C2. In the left quadrants (particularly six chemokines upon oS100A4) are
those either down-regulated and/or affected by other factors.
FIGURE 6 | PRDM8 knockdown. (A) PRDM8 transcription (measured by qRT-PCR) and (B) PRDM8 protein expression (measured by flow cytometry in permeabilized
monocytes) after 24 h. (C) Graphical representation of siRNA knockdown of PRDM8 in trained immunity (TI) on (D) IL-6 or (E) TNFα releases in oS100A4- (2µg/ml)
primed monocytes and subsequent stimulation with LPS (10 ng/ml) (n = 4 healthy donors, experiment performed in duplicate). The left panel of each figure showed
the average release of cytokines during 3 days upon oS100A4, after mock transfection (scrambled, Scr) or siRNA against PRDM8. During this latency period, PRDM8
knockdown decreased oS100A4-induced release of cytokines. The middle panel shows the release of cytokines on days 4–5; at this time, the remaining effect of
oS100A4 on cytokine release was negligible. The right panel illustrates the TI protocol in presence of LPS. Compared to controls (Scr), the response to LPS was
significantly increased in oS100A4 (+Scr)-pretreated monocytes (arrow). sIRNA against PRDM8 increased the response to LPS in untreated cells. However, in the
context of oS100A4-primed cells, the opposite occurs; TI was abolished and the response to LPS was strongly reduced.
Frontiers in Immunology | www.frontiersin.org 11 April 2019 | Volume 10 | Article 791
Neidhart et al. DAMPS and Trained Immunity
FIGURE 7 | S100A4 and PRDM8 associations with the pathogenesis of RA. (A) Significant Spearman’s rank correlation between plasma levels of S100A4 and CSF2
(GM-CSF). (B) Significant positive Spearman’s rank correlation coefficient between PRDM8 transcription in RA monocytes and plasma levels of CCL5. (C) Significant
positive Spearman’s rank correlation coefficient between PRDM8 transcription in RA monocytes and plasma levels of IL-6 in patients not receiving Tocilizumab. The
units on the X- and Y-axis corresponded to the respective ranks. (D) Decreased PRDM8 transcription in monocytes of patients responding to treatments or in
remission (DAS28 < 2.6, BSE < 20 mm/h and CRP < 5 mg/L).
The discrepancy between up-regulation of transcripts and
missing release could be due at least in part to increased
degradation in proteasomes (28, 29).
oS100A4 Priming and Trained Immunity
As a second stimulus, oS100A4 produced similar responses as
LPS. Thus, in β-glucan-trained monocytes, it increases release
of IL-6 and TNFα, while in LPS-pre-treated cells releases upon
oS100A4 of those cytokines were drastically inhibited. Most
importantly, oS100A4-pretreated monocytes not only showed a
lack of tolerance to LPS, but they even increased releases of
IL-6, TNFα and IL-1β in response to LPS. A S100A4-mediated
increased response to LPS can be relevant in pathogenesis
(30). Of interest was the increased transcription and release
of CSF2 upon oS100A4 exposure. In mice, CSF2 positively
influences the TI phenomenon (31). A possibility is that CSF2
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FIGURE 8 | Differences between β-glucan and oS100A4. (A) Effect of pre-treatment with β-glucan or oS100A4 on LPS-induced transcription of IL6 and TNF (n = 3).
β-Glucan, but not oS100A4, causes increased IL6 and TNF transcription. (B) RNASeq showed decreased transcription of SCIN and C) flow cytometry in
permeabilized monocytes confirmed the reduction in scinderin (SCIN) upon oS100A4. (D) Increased transcription of Ca++ channel subunit CACNA1E upon oS100A4
(from RNASeq data).
enhances TNFα production, not before but after additional LPS
stimulation (32).
Epigenetic Mechanisms and Similarities
Between β-glucan and oS100A4
We performed RNASeq after exposure to β-glucan or oS100A4
and found similarities particularly for chemokines/cytokines and
epigenetic effectors. Previously epigenetic reprogramming has
been proposed as the molecular basis of TI (19, 33, 34). Upon
β-glucan and oS100A4, our RNASeq data suggested activation
of both global (HMGA2, SMARCA1) and specific epigenetic
modifications. This regards upregulation of mechanisms leading
to histone acetylation (CITED4, DPF3, MN1, TMEM44),
deacetylation (HDAC7, 9, 11) and methylation (FAM86B1,
PRDMs) as well as possibly to differential promoter methylation
(DNMT3B, NCAPG) or demethylation (GADD45B).
Histone modifications are associated with transcriptional
repression or activation, depending on the type of modification
and locus modified. Methylation of lysine and arginine residues
also can result in transcriptional activation. For instance, in
rats, histone methylation is associated with persistent release
of pro-inflammatory cytokines (35). Particularly interesting
are the increased transcription of PR/SET domain proteins
(PRDMs) encoding for histone methyltransferases. PRDMs are
implicated in fundamental aspects of cellular differentiation
(36, 37). Upregulated PRDM8 transcription correlated with 31
chemokines/cytokines mRNAs, including CCL5, CCL20, CSF2,
IL6, and TNFA. The importance of PRDM8 is emphasized by
its central position in the Venn diagram, suggesting a key role
in chemokine and cytokine regulation for both stimuli. Very
few biological functions are known for PRDM8, with exception
that in mice fibroblasts it methylates histone H3K9 and exerts
a negative regulatory role on murine steroidogenesis (38); in
addition, in mice, it is required for normal development of the
neocortex (39). Thus, it was important to clarify its role during
the process of TI.
Histone Demethylase PRDM8 as a Switch
in Trained Immunity
PRDM8 knockdown increased the release of IL-6 and TNFα
after stimulation with LPS. Thus, in the context of an endotoxin
stimulation, PRDM8 may limit the pro-inflammatory response,
as expected from a histone methylase. However, the situation
is completely different in oS100A4-primed monocytes; siRNA
against PRDM8 not only decreased the release of IL-6 and TNFα
upon oS100A4, they also abolished oS100A4-induced TI. In this
sequence, the effect of oS100A4 dominates over LPS, probably
due to global chromatin modifications. PRDMs either act as
direct histone methyltransferases or recruit a suite of histone-
modifying enzymes to target promoters (37). Previously, it has
been shown in mice that a histone demethylase inhibitor (but not
a histone methylase inhibitor) abolished TI (19).
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FIGURE 9 | Working hypothesis: Differences between (A) β-glucan- and (B) oS100A-induced trained immunity.
A limitation of the study could be the fact that monocytes
from healthy donors, instead of RA treatment naïve patients
were used. In patients, pre-existing chromatin changes or
gene polymorphism could affect TI. Another limitation is that
our analysis considers the response of monocytes to single
exposure with β-glucan or oS100A4, reflecting how the cells are
modified before they respond to a second stimulus. Interestingly,
additional observations suggested that the mechanisms leading
to an increased release of pro-inflammatory cytokines in fact are
different between β-glucan- or oS100A4-pretreated monocytes.
TI has been defined by increased release of pro-inflammatory
cytokines into the culture supernatant and not necessarily by
increased transcription. β-Glucan induces activation histone
marks on the IL-6 and TNFα promoters, in particular H3K4
methylation (21). Thus, as expected, upon re-stimulation with
LPS, β-glucan-trained monocytes increased the transcription
of IL6 and TNF, i.e., higher than with LPS alone. This
is followed by increased release. Monocytes primed with
oS100A4 and re-stimulated with LPS, however, showed no
more transcription of IL6 and TNF than cells exposed to
LPS alone. An additional mechanism upon oS100A4 could
be related to the downregulation of scinderin (SCIN), which
controls the cortical membrane actin filament network. In
addition, upregulation of ion channels might render monocytes
more reactive to further stimuli; in particular CACNA1E,
which encodes the alpha-1E subunit of the R-type Ca++
channels. The fact that SNX482 (a potent and selective, voltage-
dependent R-type Ca++ channel blocker) inhibits LPS-induced
release of IL-6 and TNFα (Supplementary Figure 6) suggests
that upregulation of Ca++ channels could play a role in
the increased response to a second stimulus. According to
NCBI Genes, these channels mediate the entry of Ca++ into
excitable cells and are also involved in a variety of Ca++-
dependent processes, including muscle contraction, hormone,
or neurotransmitter release, gene expression, cell motility,
cell division and cell death. It is important to note that
such processes also can be regulated by epigenetics (40, 41).
Massive chromatin modifications occurred, as suggested by
up-regulations of genes such as HMGA2, B2, or SMARCA1.
Therefore, it will be interesting to investigate the effect of
DAMPs on chromatin using a more global approach, such
as ATAQ-Seq.
Monocyte Training in Rheumatoid Arthritis
In RA, elevated plasma S100A4 significantly correlated with
increased CSF2, in accordance with the effect of oS100A4 on
CSF2 release in vitro. In 31% of RA patients, the plasma
level of S100A4 can reach 2µg/ml (12); in 46% of the RA
synovial fluid, it ranges from 2 to 7µg/ml. The possibility
that peripheral blood macrophages in RA are trained is an
important issue in the context of chronic inflammation and
comorbidity with cardiovascular diseases (2, 22, 27, 42). In
RA monocytes, gene expression of several proinflammatory
cytokines are increased. They spontaneously showed higher
releases of IL-1β and IL-6 (but not TNFα) (1). A recent study
(43) reports unchanged ex vivo responses to LPS between healthy
donors and RA patients; the authors didn’t identify an increase
in H3K4me3 at IL6 and TNF promoters and therefore rejected
the TI hypothesis in RA. In fact, it is even surprising that
RA monocytes are not tolerant to LPS, being confronted to an
environment with multiple TLR2/TR4-ligands. Our data showed
that DAMPs probably induced a form of TI through other
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mechanisms. More recently, a shift toward glycolysis has been
reported in RA peripheral blood monocytes (2) that resembles
trained monocytes (32, 42). In RA, the level of PRDM8 mRNAs
correlated with plasma levels of CCL5; this might be a sign that
DAMPs influence the activity of monocytes. Another argument
in favor of the TI hypothesis in RA monocytes is the positive
association between PRDM8 and plasma levels of IL-6; this is not
shown by healthy donors. Both the RNASeq correlation analysis
upon stimulation and the PRDM8 knockdown experiment
predicted a positive association between PRDM8 and IL-6 in
trained monocytes. Finally, increased PRDM8 transcription was
associated with therapy-resistance.
In RA, extracellular S100A4 released by activated synovial
fibroblasts is involved in the paracrine regulation of several
matrix-degrading enzymes andmodulation of the transcriptional
activation function of the tumor suppressor protein p53
(44). In S100A4-stimulated PMBCs, enhanced production of
proinflammatory cytokines is at least partly mediated by
activation of the transcription factor NF-κB and theMAP kinases
p38 and ERK1/2 (13). S100A4 also influences the phenotype and
activity of endothelial cells (45) and vascular smooth muscle cells
(46). Thus, S100A4 could be involved in the comorbidity of RA
such as cardiovascular diseases.
Finally, additional studies have to investigate whether
autocrine/paracrine factors, such as S100A8/S100A9 or CSF2,
play a role in DAMPs-induced TI.
In conclusion, even in the case that DAMPs act via
TLR2/TLR4, this doesn’t result in endotoxin tolerance. The
bypass of tolerance might be a phenomenon as important
as TI, since it could explain how chronic inflammation can
be maintained. It also allows trained monocytes to respond
adequately to infection. At concentrations measured in
RA plasma, oS100A4 can induce TI. Interestingly, many
similarities in chemokine/cytokine/epigenetic effectors and
their relationships were found between β-glucan and oS100A4.
The effect of β-glucan was explained through activating
histone modifications at the IL6 and TNF loci and increased
transcription upon second stimulus. This is less obvious
regarding oS100A4-treated monocytes or RA monocytes.
Nevertheless, the training effect of oS100A4 could be explained
at different levels, including chromatin remodeling, together
with changes in the cytoskeleton and secretory machinery
(Figure 9). In association with epigenetic modifications, we
suggested that upregulated histone methylase PRDM8 plays a
key role in driving the cytokine/chemokine response. In RA
monocytes, a PRDM8-dependent training mechanism could
be responsible for sustained release of IL-6 and possibly other
chemokines/cytokines. Through better understanding the
effect of DAMPs on monocytes, novel therapeutic strategies
could be developed, based on the inhibition of specific
epigenetic mechanisms.
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Supplementary Figure 1 | Examples of dose responses effects of DAMPs in the
TI/tolerance protocol. Peripheral blood monocytes were exposed to increasing
doses of DAMPs for 24 h and stimulated with 10 ng/ml LPS 3 days later (n = 8
healthy donors). IL-6 and TNFα were measured by ELISA in the cell culture
supernatant. (A,B) 2.5–5.0µg/ml oS100A4 showed TI for both IL-6 and TNFα.
(C,D) 1.25–1.5µg/ml HMGB1 induced TI more for IL-6 than TNFα. (E,F) 0.31–2.5
mg/ml tenascin C is associated with TI for TNFα only, at higher doses it produced
tolerance. (G,H) HSP90 produced weak TI for both IL-6 and TNFα. The upper full
line labeled βG represents the median TI obtained with 1µg/ml β-glucan. The
dotted line represents the baseline; the gray zone labeled LPS shows the zone of
endotoxin tolerance, i.e., below the median obtained with repeated exposure to
LPS (1 ng/ml followed by 10 ng/ml 3 days later).
Supplementary Figure 2 | Parts of the confirmation experiment regarding
repeated exposures with the same stimulus. (A,B) β-Glucan by itself did not result
in tolerance, in contrast to the repeated exposure to LPS. At opposite, after
repeated stimulation with β-glucan, a detectable increase of TNFα release can
occur. (C) Repeated oS100A4 stimulations didn’t modify the release of cytokines
and most importantly didn’t result in tolerance. Peripheral blood monocytes from
healthy donors were exposed to 1µg/ml β-glucan, 2µg/ml oS100A4 or 1 ng/ml
LPS for 24 h and 3 days later were re-exposed to the same stimulus. Cytokines in
the cell culture supernatant were measured by ELISA.
Supplementary Figure 3 | Quantitative real-time PCR. (A) Chemokine and
(B) cytokine transcripts in monocytes exposed to 1µg/ml β-glucan or 2µg/ml
oS100A4.
Supplementary Figure 4 | Human XL Cytokine Array (R&D
Systems)—Representative examples of cell culture supernatants: (A) untreated
(control) CD14+ monocytes, (B) stimulated with 1µg/ml β-glucan (increased
CCL5, but no IL-6 or TNFα) or (C) 2µg/ml oS100A4 (increased CCL5, CCL20
[MIP-3α], CSF2 [GM-CSF, CXCL1, IL-1β, IL-6, only weakly TNFα).
Supplementary Figure 5 | Changed gene expression of chemokines and
cytokines upon (A,C) β-glucan (1µg/ml) or (B,D) oS100A4 (2µg/ml), as revealed
by RNASeq (mean and median > 2-fold significantly increased, box-and-whisker
plots, n = 5 healthy donors in duplicate, Mann–Whitney U–test). (E) Released
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CCL5 and (F) CSF2 into the cell culture supernatant, as measured by ELISA
(n = 10 healthy donors, Wilcoxon signed-rank test).
Supplementary Figure 6 | R-type Ca++ channel inhibition decreased
LPS-induced releases of IL-6 and TNFα from undifferentiated and
PMA-differentiated THP-1 cells. (A,B) Within 1 h upon LPS, releases of IL-6 and
TNFα from THP-1 cells into culture supernatant are inhibited by 25 nM SNX482.
(C,D) Within 24 h upon LPS, releases of IL-6 and/or TNFα are inhibited by 25 nM
SNX482, particularly by PMA-differentiated THP-1 cells (experiment in triplicate,
paired t-test).
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